176 related articles for article (PubMed ID: 21246364)
41. Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.
Ursum J; Bos WH; van Dillen N; Dijkmans BA; van Schaardenburg D
Arthritis Res Ther; 2010; 12(1):R8. PubMed ID: 20064278
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
43. [Serum immunoglobulin patterns in rheumatoid arthritis].
Dreher R
Z Rheumatol; 1977; 36(1-2):3-21. PubMed ID: 842145
[TBL] [Abstract][Full Text] [Related]
44. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement.
Ribeiro SL; Pereira HL; Silva NP; Neves RM; Sato EI
Braz J Med Biol Res; 2008 Nov; 41(11):1005-10. PubMed ID: 19099154
[TBL] [Abstract][Full Text] [Related]
45. The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations.
Willemze A; Shi J; Mulder M; Stoeken-Rijsbergen G; Drijfhout JW; Huizinga TW; Trouw LA; Toes RE
Ann Rheum Dis; 2013 Jun; 72(6):1059-63. PubMed ID: 23486413
[TBL] [Abstract][Full Text] [Related]
46. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
[TBL] [Abstract][Full Text] [Related]
47. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
48. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
[TBL] [Abstract][Full Text] [Related]
49. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
[TBL] [Abstract][Full Text] [Related]
50. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
Front Immunol; 2018; 9():2388. PubMed ID: 30420853
[TBL] [Abstract][Full Text] [Related]
51. What is the ability of anti-cyclic citrullinated peptide antibodies determination in synovial fluid in discriminating rheumatoid arthritis from non-rheumatoid arthritis patients? A Tunisian cross-sectional study.
Mrabet D; Laadhar L; Sahli H; Zouari B; Haouet S; Lahmar H; Makni S; Sellami S
Clin Rheumatol; 2012 Feb; 31(2):375-9. PubMed ID: 21952975
[TBL] [Abstract][Full Text] [Related]
52. [IgM, IgG and IgA rheumatoid factors in rheumatoid arthritis].
Naranjo Hernández A; Muniain Ezcurra MA; Vargas Lebrón MC; Rodríguez Barrera JM; Prieto Martínez J; Navarro Sarabia F
An Med Interna; 1989 Nov; 6(11):575-9. PubMed ID: 2562699
[TBL] [Abstract][Full Text] [Related]
53. Detection of IgM-rheumatoid factor and anti-citrullinated protein antibodies in healthy horses and their comparison.
Hoikhman R; Kudlackova H; Babak V; Faldyna M; Jahn P
Vet Immunol Immunopathol; 2018 Aug; 202():141-146. PubMed ID: 30078588
[TBL] [Abstract][Full Text] [Related]
54. Anti-citrullinated peptide antibody: death of the rheumatoid factor?
Chatfield SM; Wicks IP; Sturgess AD; Roberts LJ
Med J Aust; 2009 Jun; 190(12):693-5. PubMed ID: 19527206
[TBL] [Abstract][Full Text] [Related]
55. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
56. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis.
Bas S; Genevay S; Meyer O; Gabay C
Rheumatology (Oxford); 2003 May; 42(5):677-80. PubMed ID: 12709545
[TBL] [Abstract][Full Text] [Related]
57. [Association of markers of rheumatoid arthritis in lupus. Is it a rhupus?].
Bouchedoub Y; Djenouhat K; Rachedi N; Babasaci R; Ould Ali L; Salah K; Kherrache R; Kherbeche M; Khlifati A; Guernou FZ; Benzitouni A; Semmana M; Meghlaoui A
Ann Biol Clin (Paris); 2020 Apr; 78(2):201-205. PubMed ID: 32319950
[TBL] [Abstract][Full Text] [Related]
58. Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines).
Westra J; Brouwer E; Raveling-Eelsing E; Arends S; Eman Abdulle A; Roozendaal C; van Delft MAM; Toes REM; Trouw LA; Vissink A; de Smit MJ
Rheumatology (Oxford); 2021 Feb; 60(2):658-666. PubMed ID: 32594174
[TBL] [Abstract][Full Text] [Related]
59. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.
Bertin D; Dubucquoi S; Lakomy D; Deleplancque AS; Desplat-Jégo S
Immunol Res; 2016 Apr; 64(2):455-60. PubMed ID: 26350265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
